Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 133,523 |
|
|||||
| News | - | ||||||
| Day High | 1.60 | Low High |
|||||
| Day Low | 1.50 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cel Sci Corporation New | CVM | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -1.32% | 1.50 | 17:59:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.54 | 1.50 | 1.60 | 1.50 | 1.52 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 944 | 133,523 | $ 1.54 | $ 205,961 | - | 1.04 - 3.23 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 1,047 | $ 1.50 | USD |
Cel Sci Corporation New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 78.92M | 52.26M | - | 0 | -32.37M | -0.62 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cel Sci News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.70 | 1.71 | 1.50 | 1.62 | 174,714 | -0.20 | -11.76% |
| 1 Month | 2.02 | 2.05 | 1.50 | 1.78 | 257,942 | -0.52 | -25.74% |
| 3 Months | 2.71 | 3.08 | 1.50 | 2.20 | 322,648 | -1.21 | -44.65% |
| 6 Months | 1.12 | 3.23 | 1.04 | 1.95 | 845,941 | 0.38 | 33.93% |
| 1 Year | 2.49 | 3.23 | 1.04 | 1.94 | 553,191 | -0.99 | -39.76% |
| 3 Years | 17.05 | 27.86 | 1.04 | 6.90 | 745,158 | -15.55 | -91.20% |
| 5 Years | 6.06 | 40.91 | 1.04 | 9.26 | 763,982 | -4.56 | -75.25% |
Cel Sci Description
| CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. |
